The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Arsenic trioxide — An old drug rediscovered
Open accessAbstract
Over the last 17 years, clinical trials conducted worldwide have demonstrated the efficacy of arsenic trioxide (As2O3) in the treatment of relapsed acute promyelocytic leukemia (APL). Currently, the role of As2O3 in front-line therapy is under investigation. Recent trials in the US have demonstrated that the addition of As2O3 to standard treatment regimens improves survival outcomes in patients with APL and may allow a reduction in cytotoxic chemotherapy exposure. As2O3 has also shown efficacy in other malignancies, particularly multiple myeloma and myelodysplastic syndromes. Therapeutic doses of As2O3 are well tolerated, with no evidence of long-term toxicity. Adverse events include APL differentiation syndrome, electrocardiographic abnormalities, and mild elevations in liver enzymes. This review highlights trials investigating the role of As2O3 in induction and consolidation for newly diagnosed APL, as well as its role in other hematologic malignancies. The chemistry, mechanisms of action, and clinical side effects of As2O3 are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9
Zou, H., Li, Y., Liu, X., & Wang, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11549 · Cited by 2,090
Shen, Z.-X., Chen, G.-Q., Ni, J.-H., Li, X.-S., Xiong, S.-M., Qiu, Q.-Y., Zhu, J., Tang, W., Sun, G.-L., Yang, K.-Q., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3354 · Cited by 1,428
Acute promyelocytic leukemia: from highly fatal to highly curable
Wang, Z.-Y., & Chen, Z. (2008) · Blood · doi:10.1182/blood-2007-07-102798 · Cited by 1,277
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
Soignet, S. L., Maslak, P., Wang, Z.-G., Jhanwar, S., Calleja, E., Dardashti, L. J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D. A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391901 · Cited by 1,213
Mechanisms of action of arsenic trioxide.
Miller, W. H., Schipper, H. M., Lee, J. S., Singer, J. W., & Waxman, S. (2002) · PubMed · Cited by 1,088
Sanz, M. A., Grimwade, D., Tallman, M. S., Lowenberg, B., Fenaux, P., Estey, E. H., Naoe, T., Lengfelder, E., Büchner, T., Döhner, H., et al. (2009) · Blood · doi:10.1182/blood-2008-04-150250 · Cited by 947
Chen, G., Zhu, J., Shi, X., Ni, J., Zhong, H., Si, G., Jin, X., Tang, W., Li, X., Xong, S., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1052.1052 · Cited by 864
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
Soignet, S. L., Frankel, S. R., Douer, D., Tallman, M. S., Kantarjian, H., Calleja, E., Stone, R. M., Kalaycio, M., Scheinberg, D. A., Steinherz, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3852 · Cited by 826
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Chen, G., Shi, X., Tang, W., Xiong, S. M., Zhu, J., Cai, X., Han, Z., Ni, J.-H., Shi, G., Jia, P.-M., et al. (1997) · PubMed · Cited by 781
Shen, Z.-X., Shi, Z.-Z., Fang, J., Gu, B.-W., Li, J.-M., Zhu, Y.-M., Shi, J.-Y., Zheng, P.-Z., Yan, H., Liu, Y.-F., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400053101 · Cited by 583
Pml is essential for multiple apoptotic pathways
Wang, Z.-G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/3073 · Cited by 558
Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.
Kanzawa, T., Kondo, Y., Ito, H., Kondo, S., & Germano, I. M. (2003) · PubMed · Cited by 548
Dai, J., Weinberg, R. S., Waxman, S., & Jing, Y. (1999) · Blood · doi:10.1182/blood.v93.1.268 · Cited by 540
Saleh, A., Srinivasula, S. M., Acharya, S., Fishel, R., & Alnemri, E. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17941 · Cited by 501
Lazo, G., Kantarjian, H., Estey, E., Thomas, D., O'Brien, S., & Cortes, J. (2003) · Cancer · doi:10.1002/cncr.11314 · Cited by 494
ENZYMATIC METHYLATION OF ARSENIC SPECIES AND OTHER NEW APPROACHES TO ARSENIC TOXICITY
Aposhian, H. V. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.397 · Cited by 426
Hu, J., Liu, Y.-F., Wu, C.-F., Xu, F., Shen, Z.-X., Zhu, Y.-M., Li, J.-M., Tang, W., Zhao, W.-L., Wu, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813280106 · Cited by 425
Reactive oxygen species in tumor metastasis
Nishikawa, M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.031 · Cited by 398
Ravandi, F., Estey, E., Jones, D., Faderl, S., O'Brien, S., Fiorentino, J., Pierce, S., Blamble, D., Estrov, Z., Wierda, W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6130 · Cited by 376
Kapahi, P., Takahashi, T., Natoli, G., Adams, S. R., Chen, Y., Tsien, R. Y., & Karin, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007204200 · Cited by 359
Redox Signaling and the Emerging Therapeutic Potential of Thiol Antioxidants
Sen, C. K. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00672-2 · Cited by 358
Park, W. H., Seol, J. G., Kim, E.-K., Hyun, J. M., Jung, C. W., Lee, C. R., Kim, B.-K., & Lee, Y. Y. (2000) · PubMed · Cited by 343
Mathews, V., George, B., Lakshmi, K. M., Viswabandya, A., Bajel, A., Balasubramanian, P., Shaji, R. V., Srivastava, V. M., Srivastava, A., & Chandy, M. (2006) · Blood · doi:10.1182/blood-2005-08-3532 · Cited by 343
Differential SMN2 expression associated with SMA severity
Gavrilov, D. K., Shi, X., Das, K., Gilliam, T. C., & Wang, C. H. (1998) · Nature Genetics · doi:10.1038/3030 · Cited by 338
Arsenite Induces Apoptosis via a Direct Effect on the Mitochondrial Permeability Transition Pore
Larochette, N., Decaudin, D., Jacotot, E., Brenner, C., Marzo, I., Susin, S. A., Zamzami, N., Xie, Z., Reed, J., & Kroemer, G. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4519 · Cited by 301
Reviews in biochemical toxicology
Hodgson, E., Bend, J. R., & Philpot, R. M. (1979) · Elsevier eBooks · Cited by 274
Zhu, X.-H., Shen, Y.-L., Jing, Y.-K., Cai, X., Jia, P.-M., Huang, Y., Tang, W., Shi, G.-Y., Sun, Y.-P., Dai, J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.9.772 · Cited by 272
Ascorbic acid enhances arsenic trioxide–induced cytotoxicity in multiple myeloma cells
Grad, J. M., Bahlis, N. J., Reis, I., Oshiro, M. M., Dalton, W. S., & Boise, L. H. (2001) · Blood · doi:10.1182/blood.v98.3.805 · Cited by 271
Rousselot, P. H., Labaume, S., Marolleau, J., Larghero, J., Noguera, M., Brouet, J. C., & Fermand, J. (1999) · PubMed · Cited by 245
Chou, W.-C., Jie, C., Kenedy, A. A., Jones, R. J., Trush, M. A., & Dang, C. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306687101 · Cited by 234
Spuches, A. M., Kruszyna, H. G., Rich, A. M., & Wilcox, D. E. (2005) · Inorganic Chemistry · doi:10.1021/ic048694q · Cited by 206
Kchour, G., Tarhini, M., Kooshyar, M.-M., El Hajj, H., Wattel, E., Mahmoudi, M., Hatoum, H., Rahimi, H., Maleki, M., Rafatpanah, H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211821 · Cited by 199
Bahlis, N. J., Grad, J. M., Jordan-McMurry, I., Neil, J., Reis, I., Kharfan‐Dabaja, M. A., Eckman, J. R., Goodman, M. S., Fernandez, H. F., Boise, L., et al. (2002) · PubMed · Cited by 190
Adès, L., Chevret, S., Raffoux, E., de Botton, S., Guerci, A., Pigneux, A., Stoppa, A. M., Lamy, T., Rigal-Huguet, F., Vekhoff, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1596 · Cited by 169
Asou, N., Kishimoto, Y., Kiyoi, H., Okada, M., Kawai, Y., Tsuzuki, M., Horikawa, K., Matsuda, M., Shinagawa, K., Kobayashi, T., et al. (2007) · Blood · doi:10.1182/blood-2006-08-043992 · Cited by 160
The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms
Zhang, W., Ohnishi, K., Shigeno, K., Fujisawa, S., Naito, K., Nakamura, S., Takeshita, K., Takeshita, A., & Ohno, R. (1998) · Leukemia · doi:10.1038/sj.leu.2401112 · Cited by 158
Biochemical toxicology of arsenic.
Aposhian, H. (1989) · Europe PMC (PubMed Central) · Cited by 155
Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial
Lin, C., Hsu, C., Hsu, C., Hsu, W.-L., Cheng, A., & Yang, C.-H. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-9004-9 · Cited by 135
Berenson, J. R., Matous, J., Swift, R. A., Mapes, R., Morrison, B., & Yeh, H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1812 · Cited by 132
Hermine, O., Dombret, H., Poupon, J., Arnulf, B., Lefrère, F., Rousselot, P. H., Damaj, G. L., Delarue, R., Fermand, J. P., Brouet, J. C., et al. (2004) · The Hematology Journal · doi:10.1038/sj.thj.6200374 · Cited by 128
Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma
Hussein, M. A., Saleh, M. N., Ravandi, F., Mason, J. R., Rifkin, R. M., & Ellison, R. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04941.x · Cited by 118
Opportunities for Trisenox® (arsenic trioxide) in the treatment of myelodysplastic syndromes
List, A. F., Beran, M., DiPersio, J. F., Slack, J. L., Vey, N., Rosenfeld, C. S., & Greenberg, P. L. (2003) · Leukemia · doi:10.1038/sj.leu.2403021 · Cited by 115
Wang, Z., Zhou, J., Lu, X., Gong, Z., & Le, X. C. (2003) · Chemical Research in Toxicology · doi:10.1021/tx0341714 · Cited by 114
Phase II Multicenter Study of Arsenic Trioxide in Patients With Myelodysplastic Syndromes
Schiller, G. J., Slack, J. L., Hainsworth, J. D., Mason, J. R., Saleh, M. N., Rizzieri, D. A., Douer, D., & List, A. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7903 · Cited by 106
Peddie, C. M., Wolf, C. R., McLellan, L. I., Collins, A. R., & Bowen, D. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4373247.x · Cited by 106
Chen, G., Zhou, L., Stýblo, M., Walton, F. S., Jing, Y., Weinberg, R. S., Chen, Z., & Waxman, S. (2003) · PubMed · Cited by 99
Park, J.-W., Choi, Y., Jang, M. A., Baek, S., Lim, J. H., Passaniti, T., & Kwon, T. K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5416 · Cited by 98
Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study
Vey, N., Bosly, A., Guerci‐Bresler, A., Feremans, W., Dombret, H., Dreyfus, F., Bowen, D., Burnett, A. K., Dennis, M., Ribrag, V., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9503 · Cited by 89
Berenson, J. R., Boccia, R. V., Siegel, D. S. D., Bozdech, M. J., Bessudo, A., Stadtmauer, E. A., Pomeroy, J. T., Steis, R. G., Flam, M. S., Lutzky, J., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06280.x · Cited by 85
A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients
Rousselot, P. H., Larghero, J., Arnulf, B., Poupon, J., Royer, B., Tibi, A., Madelaine, I., Cimerman, P., Chevret, S., Hermine, O., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403424 · Cited by 79
Role of cysteines 640, 656, and 661 in steroid binding to rat glucocorticoid receptors.
Chakraborti, P. K., Garabedian, M. J., Yamamoto, K. R., & Simons, S. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49919-5 · Cited by 78
Vitamin C protects HL60 and U266 cells from arsenic toxicity
Karasavvas, N., Cárcamo, J. M., Stratis, G., & Golde, D. W. (2005) · Blood · doi:10.1182/blood-2003-03-0772 · Cited by 66
Fujisawa, S., Ohno, R., Shigeno, K., Sahara, N., Nakamura, S., Naito, K., Kobayashi, M., Shinjo, K., Takeshita, A., Suzuki, Y., et al. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0288-4 · Cited by 63
A phase II trial of arsenic trioxide in patients with metastatic melanoma
Kim, K. B., Bedikian, A. Y., Camacho, L. H., Papadopoulos, N. E., & McCullough, C. (2005) · Cancer · doi:10.1002/cncr.21386 · Cited by 62
The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms
張, 文. (2000) · Institutional Repositories DataBase (IRDB) · doi:10.11501/3165072 · Cited by 59
Roboz, G. J., Ritchie, E. K., Curcio, T. J., Provenzano, J. L., Carlin, R. F., Samuel, M., Wittenberg, B., Mazumdar, M., Christos, P. J., Mathew, S., et al. (2008) · Cancer · doi:10.1002/cncr.23855 · Cited by 50
Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: Results of a Phase II Randomized Trial
Qazilbash, M. H., Saliba, R. M., Nieto, Y. L., Parikh, G. C., Pelosini, M., Khan, F. B., Jones, R. B., Hosing, C. M., Mendoza, F. L., Weber, D. M., et al. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.09.019 · Cited by 47
Abou-Jawde, R. M., Reed, J., Kelly, M., Walker, E., Andresen, S. W., Baz, R., Karam, M. A., & Hussein, M. A. (2006) · Medical Oncology · doi:10.1385/mo:23:2:263 · Cited by 45
Chang, J., Voorhees, P., Kolesar, J., Ahuja, H., Sanchez, F., Rodriguez, G., Kim, K., Werndli, J. E., Bailey, H., & Kahl, B. S. (2008) · Hematological Oncology · doi:10.1002/hon.870 · Cited by 37
Wu, K. L., Beksaç, M., Droogenbroeck, J. V., et al. (2006) · PubMed · Cited by 32
Dilda, P. J., Perrone, G. G., Philp, A., Lock, R. B., Dawes, I. W., & Hogg, P. J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.002 · Cited by 31
History of the Treatment of Chronic Myelocytic Leukemia
Sears, D. A. (1988) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198808000-00001 · Cited by 24
Ishitsuka, K., Suzumiya, J., Aoki, M., Ogata, K., Hara, S., & Tamura, K. (2007) · Haematologica · doi:10.3324/haematol.10703 · Cited by 22
Cited by
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,834
Autophagy as a molecular target for cancer treatment
Kocaturk, N. M., Akkoc, Y., Kig, C., Bayraktar, O., Gozuacik, D., & Kutlu, O. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.011 · Cited by 387
Kim, J., Aftab, B. T., Tang, J. Y., Kim, D., Lee, A. H., Rezaee, M., Kim, J., Chen, B., King, E. M., Borodovsky, A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.017 · Cited by 346
What has traditional Chinese medicine delivered for modern medicine?
Wang, J., Wong, Y.-K., & Liao, F. (2018) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2018.3 · Cited by 328
Pathways of Arsenic Uptake and Efflux
(2012) · Current Topics in Membranes · doi:10.1016/b978-0-12-394390-3.00012-4 · Cited by 301
Metadata
- Authors
- Emadi, A., & Gore, S. D.
- Venue
- Blood Reviews
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 24
- Issue
- 4-5
- Pages
- 191-199
- ISSN
- 0268-960X (ISSN-L)
- OpenAlex
- W2111279921
- Cited by
- 279
- References
- 68
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.